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c o n c i s e c o m m u n i c a t i o n
Implementing Automated Surveillance
for Tracking Clostridium difficile
Infection at Multiple Healthcare
Facilities
Erik R. Dubberke, MD, MSPH;1
Humaa A. Nyazee, MPH;1 Deborah S. Yokoe, MD;2
Jeanmarie Mayer, MD;3 Kurt B. Stevenson, MD, MPH;4
Julie E. Mangino, MD;4 Yosef M. Khan, MD;4
Victoria J. Fraser, MD1
for the Centers for Disease Control and
Prevention Epicenters Program
Automated surveillance using electronically available data has been
found to be accurate and save time. An automated Clostridium dif-
ficile infection (CDI) surveillance algorithm was validated at 4 Cen-
ters for Disease Control and Prevention Epicenter hospitals. Elec-
tronic surveillance was highly sensitive, specific, and showed good
to excellent agreement for hospital-onset; community-onset, study
facility–associated; indeterminate; and recurrent CDI.
Infect Control Hosp Epidemiol 2012;33(3):305-308
It is recommended that all US hospitals track Clostridium
difficile infection (CDI).1 At a minimum, it is recommended
to conduct surveillance for hospital-onset CDI, but tracking
CDI with onset in the community may have important ep-
idemiological and prevention implications.1,2 However, sur-
veillance for community-onset CDI is much more labor in-
tensive than for hospital-onset CDI. Due to increased demand
for patient safety coupled with an emphasis to adopt and
implement electronic health records, automated surveillance
systems for tracking nosocomial infections needed to be in-
vestigated to maximize both limited resources and patient
safety.3,4 The goal of this study was to develop and validate
an automated CDI surveillance algorithm using electronically
available data at multiple healthcare facilities.
methods
The study population included all adult patients ≥18 years
of age admitted to 4 US hospitals participating in the Centers
for Disease Control and Prevention (CDC) Epicenters Pro-
gram from July 1, 2005, to June 30, 2006. These hospitals
included Barnes-Jewish Hospital (St. Louis, MO), Brigham
and Women’s Hospital (Boston, MA), Ohio State University
Medical Center (Columbus, OH), and University Hospital
(Salt Lake City, UT).
A conceptual automated CDI surveillance algorithm was
created by using recommended surveillance definitions (Fig-
ure 1).1 Each center worked with its medical informatics de-
partments to apply the algorithm to its local databases. CDI
case categorizations by the algorithm were compared to cat-
egorizations previously determined by chart review.5 A second
chart review was performed for discordant results. The gold
standard comparison was all concordant cases and the cat-
egorization determined to be correct by the rereview. The
algorithms were modified as needed to improve accuracy.
Sensitivities and specificities were calculated for each CDI
surveillance definition. Kappa (k) statistics were also calcu-
lated. Statistical analyses were performed with SPSS for Win-
dows, version 19.0 (SPSS).
results
There were 1,767 patients with stool that tested positive for
C. difficile toxins identified. After the initial comparison of
the algorithm’s categorization of CDI cases to categorizations
determined by chart review, hospital A had 204 discordant
cases (27.1%), hospital B had 77 cases (18.7%), hospital C
had 55 cases (22.4%), and hospital D had 104 cases (29.1%).
Data on discordant cases were submitted back to the appro-
priate hospitals for rereview.
The overall sensitivities, specificities, and k-values of the
algorithm by CDI onset compared to the gold standard were
as follows: hospital onset: 92%, 99%, and 0.90; community
onset, study facility–associated: 91%, 98%, and 0.84; com-
munity onset, other healthcare facility associated: 57%, 99%,
and 0.65; community onset, community associated: 96%,
94%, and 0.69; indeterminate cases: 80%, 98%, and 0.76; and
recurrent cases: 94%, 99%, and 0.94 (Table 1). Similar sen-
sitivity, specificity, and k-values were seen at all individual
hospitals for community-onset, study-center–associated, and
recurrent CDI (Table 1). The algorithm had excellent agree-
ment for hospital-onset CDI at each hospital—except for
hospital B. Community-onset and other healthcare facil-
ity–associated CDI showed a wide range of sensitivities
(16%–96%) and k-values (0.25–0.93). Similar trends were
seen for community-onset, community-associated, and in-
determinate CDI.
Each hospital had to individualize the algorithm to its fa-
cility. Hospitals A, B, and C did not have discrete data on
where a patient was admitted from (eg, admit from home or
a long-term care facility), whereas hospital D did. Therefore,
categorization of community-onset cases at these hospitals
was dependent on the discharge status (eg, discharge to home
or long-term care facility) if the patient had a prior hospi-
talization in the previous 12 weeks. Hospital A has a code
for patients with frequent outpatient visits called “recurring
patients,” which has a start date of the first visit and end date
of December 31. Many recurring patients with CDI were
misclassified as hospital-onset CDI. The medical informatics
team created a new table within the database that contained
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figure 1. Conceptual automated CDI surveillance algorithm.
information regarding the visit type associated with a given
encounter to correct this problem. Hospital B made minor
modifications to the hospital-onset time cutoff to improve
accuracy. Hospital C was not able to modify its algorithm
because some data were available only through free text fields.
Hospital D initially included patients who were admitted to
only 1 particular building, missing those patients who were
admitted to the other 3 buildings of their medical center. This
was corrected. Three other issues were identified and resolved
after the initial review of discordant cases: outpatient en-
counters were included when determining case categorization
rather than only inpatient encounters; only the first positive
C. difficile toxin result per patient was evaluated, so subse-
quent episodes of CDI were missed; and stool collection date
was used to identify patients instead of the admit date.
discussion
The goal of this study was to develop and validate an au-
tomated CDI surveillance algorithm using existing electron-
ically available data. Previous research indicates that elec-
tronic surveillance is more accurate and reliable than manual
surveillance.3,6 Automated surveillance also requires less time
because it eliminates the need to do chart review. This study
found automated CDI surveillance to be feasible and reliable
with overall good to excellent agreement for hospital-onset;
automated cdi surveillance 307
table 1. Sensitivities, Specificities, and k-values by CDI Onset and Facility
Hospitala
Case definition A B C D Total
Healthcare facility onset 99, 98 (.97) 75, 99 (.66) 94, 100 (.93) 100, 99 (.99) 92, 99 (.90)
Community onset, study
center associated 93, 96 (.83) 100, 97 (.86) 84, 99 (.83) 81, 100 (.88) 91, 98 (.84)
Community onset, other
healthcare facility
associated 16, 99 (.25) 82, 98 (.61) 53, 98 (.59) 96, 98 (.93) 57, 99 (.65)
Community associated,
community onset 91, 95 (.71) 100, 87 (.63) 100, 92 (.44) 100, 99 (.91) 96, 94 (.69)
Indeterminate 83, 98 (.80) 73, 98 (.63) 63, 97 (.48) 84, 99 (.88) 80, 98 (.76)
Recurrent 99, 99 (.97) 88, 99 (.85) 64, 100 (.77) 97, 100 (.98) 94, 99 (.94)
a Data are percentages of sensitivity, specificity (k-value).
community-onset, study facility–associated; indeterminate;
and recurrent CDI case categorizations.
Hospitals worked with their individual information tech-
nology teams to apply the general automated CDI surveillance
algorithm to the data available at their facilities. In this study,
data availability and type of data varied from hospital to
hospital, thus impacting the accuracy of the automated al-
gorithm. This issue is illustrated by hospital D, the hospital
that performed the best at categorizing community-onset CDI
because there was a discrete variable that captured where
patients were admitted from.
There are potential limitations to the use of an automated
CDI surveillance algorithm. Electronic surveillance requires
access to an electronic health record (EHR) system. Only
∼12% of US hospitals have an EHR system.7 To develop an
automated algorithm, surveillance rules need to be specified
into electronic algorithm rules. This can lead to algorithms
that vary from site to site based on data availability. As a
result, each center can potentially have different rules for the
same infection, resulting in different rates, making interhos-
pital comparisons difficult.3
Another limitation of using an automated CDI surveillance
algorithm is that chart review is not performed. Although the
lack of chart review is mitigated by enforcing toxin testing
of only diarrheal stool, misclassification is still possible. It is
possible that a true community-onset CDI case could be mis-
classified as a hospital-onset CDI case if stool were collected
after the hospital-onset cutoff date. In addition, patients with
a positive assay for C. difficile may not have clinically sig-
nificant diarrhea and therefore do not truly have CDI. This
may be especially problematic at hospitals that use nucleic
acid amplification tests.8
This study found automated electronic CDI surveillance
to be highly sensitive and specific for identifying cases of
hospital-onset; community-onset, study center–associated;
and recurrent CDI. Automated CDI surveillance will allow
infection preventionists to devote more time to infection pre-
vention efforts. In addition, automated CDI surveillance may
facilitate a healthcare facility’s ability to track community-
onset CDI. Community-onset CDI likely contributes to hos-
pital-onset CDI because patients admitted to a healthcare
facility with CDI are a source of C. difficile transmission to
other patients. Understanding the burden of community-
onset CDI may allow for targeting of CDI prevention efforts.2
Implementing an automated algorithm using electronically
available data is feasible and reliable.
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